Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer

被引：0
|
作者：
Powles, Thomas
Sharpe, Kevin
Berney, Dan
Kayani, Irfan
Doshi, Rukma
Stewart, Grant Duncan
Reynolds, Andrew
Bex, Axel
Sarwar, Naveed
Chowdhury, Simon
机构：
[1] Barts Canc Inst, London, England
[2] Univ Colorado Hosp, London, England
[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[4] Inst Canc Res, London SW3 6JB, England
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Guys & St Thomas NHS Fdn Trust, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
437
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    LABORATORY INVESTIGATION, 2013, 93 : 239A - 239A
  • [42] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    MODERN PATHOLOGY, 2013, 26 : 239A - 239A
  • [43] High Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma in the VEGF Targeted Era
    Fitzpatrick, A.
    Soosaipillai, G.
    Wilson, P.
    Powles, T.
    Shamash, J.
    CLINICAL ONCOLOGY, 2015, 27 (03) : E7 - E8
  • [44] Targeted therapy of renal cell cancer
    Wysocki, Piotr J.
    Zolnierek, Jakob
    Szczylik, Cezaryl
    Mackiewicz, Andrzej
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (06) : 570 - 575
  • [45] Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma
    Bando, Yukari
    Furukawa, Junya
    Terakawa, Tomoaki
    Harada, Kenichi
    Hinata, Nobuyuki
    Nakano, Yuzo
    Fujisawa, Masato
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (08) : 1313 - 1318
  • [46] The role of targeted therapy in metastatic renal cell carcinoma
    Unnithan, Jaya
    Rini, Brian I.
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 800 - 807
  • [47] An update on targeted therapy in metastatic renal cell carcinoma
    Lombardi, Giuseppe
    Zustovich, Fable
    Donach, Martin
    Dalla Palma, Maurizia
    Nicoletto, Ornella
    Pastorelli, Davide
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (03) : 240 - 246
  • [48] Genomic differences and survival in African Americans with metastatic clear cell renal cell carcinoma in the targeted therapy era.
    Rose, Tracy Lynn
    Krishnan, Bhavani
    Kuykendal, Adam Rea
    Smith, Angela
    Milowsky, Matthew I.
    Kim, William Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [49] Targeted molecular therapy for renal cell carcinoma
    Lane, Brian R.
    Rini, Brian I.
    Novick, Andrew C.
    Campbell, Steven C.
    UROLOGY, 2007, 69 (01) : 3 - 10
  • [50] Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF).
    Ged, Yasser
    Gupta, Ruby
    Duzgol, Cihan
    Shapnik, Natalie
    Redzematovic, Almedina
    Kotecha, Ritesh
    Voss, Martin Henner
    Feldman, Darren R.
    Akin, Oguz
    Patil, Sujata
    Motzer, Robert J.
    Rini, Brian I.
    Lee, Chung-Han
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345